Oxipital AI Closes Series A Funding Round for Commercial Expansion
Oxipital AI has completed its Series A funding round, co-led by SAS Private Equities and Scale Venture Partners. The investment aims to accelerate the deployment of its AI-powered manufacturing solutions.
Oxipital AI, a company specializing in AI solutions, announced today the successful closure of its Series A funding round. The round was co-led by investment firms SAS Private Equities and Scale Venture Partners. The company plans to utilize the capital raised to accelerate the commercial expansion and adoption of its V-CORTX Vision platform.
The V-CORTX platform is designed to provide visual intelligence for manufacturing operations, particularly within the food industry. Funding is expected to support the wider implementation of AI-driven quality control, process optimization, and anomaly detection systems in factories.
Oxipital AI aims to assist manufacturing companies in modernizing their operations through enhanced AI capabilities. The technology is intended to improve production efficiency and product quality by enabling real-time analysis and problem-solving. Further details regarding the company's expansion plans are anticipated.